JNJ - BeiGene AbbVie patent spat to get trial from USPTO appeals board
2024-05-01 16:12:21 ET
More on AbbVie, BeiGene
- AbbVie: The Inevitable Is Happening
- Unveiling AbbVie's Winning Strategy In Pharmaceutical Innovation (Rating Upgrade)
- AbbVie stock slides 6% amid concerns about falling Humira sales
- AbbVie Q1 report beats Street despite plunging Humira sales